Autonomous Trading Shows Artificially Intelligent Perelman Algorithm Selling Gilead Science

In this article Autonomous Trading is selling its Gilead Sciences stake with a multi-billion profit on live stream at $89 downgrading to Strong Sell, while offering a free investment lesson to biotech investors.

Artificial Intelligent Algorithm Perelman light years ahead of competitors.

Peremal algorithm is being used to invest in stocks, ETF's, Forex and commodities, while Evident algorithm is being used to trade crypto currencies. Both algorithms deliver 100% accuracy to investors in AI plans.

Invest in Gilead Sciences and in the biotech industry with a true market legend instead of wasting your money and time on worthless Wall Street stock forecasts. Learn how to adopt the same investment philosophy as another great investor Warren Buffett. The concept of value investing is addressed in Intuitive Code AI Live Technical Analysis course.

Downgrading Gilead Sciences to Strong Sell

Investors focused on value investment are tremendously satisfied with both short and long-term return on investment. Start today selling your investment position in Gilead Sciences reversing to the short side.

By selling Gilead Sciences at new highs reversing to the short side investors will be able to obtain the highest return on investment, now that everyone is buying. This strategy is used by Perelman algorithm. Vieira

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics in the areas of unmet medical needs in the United States, Europe, and internationally. The company's products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, and Tybost for the treatment of human immunodeficiency virus (HIV) infection in adults; and Vosevi, Vemlidy, Epclusa, Harvoni, Sovaldi, Viread, and Hepsera products for treating liver diseases. It also provides Yescarta, a chimeric antigen receptor T cell therapy for adult patients with relapsed or refractory large B-cell lymphoma; Zydelig, a PI3K delta inhibitor for certain blood cancers; Letairis, an oral formulation of an endothelin receptor antagonist for pulmonary arterial hypertension; Ranexa, a tablet to treat chronic angina; and Lexiscan, an injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. In addition, the company offers Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B; AmBisome, an antifungal agent to treat serious invasive fungal infections; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration.